menu search

Intra-cellular therapies to present at the 11th annual svb leerink global healthcare conference

NEW YORK, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical...

February 10, 2022, 8:00 am

Astrazeneca plc boosted by alexion acquisition; five newly-minted blockbusters join its medicine cabinet

AstraZeneca PLC (LSE:AZN) said five new drugs had taken on blockbuster status last year generating over US$1bn in revenues each as delivered a strong ...

February 10, 2022, 2:45 am

Astrazeneca plc boosted by alexion acquisition; five newly-minted blockbusters join its medicine cabinet

AstraZeneca PLC (LSE:AZN) said five new drugs had taken on blockbuster status last year generating over US$1bn in revenues each as delivered a strong ...

February 10, 2022, 2:45 am

Astrazeneca plc boosted by alexion acquisition; five newly-minted blockbusters join its medicine cabinet

AstraZeneca PLC (LSE:AZN) said five new drugs had taken on blockbuster status last year generating over US$1bn in revenues each as delivered a strong ...

February 10, 2022, 2:45 am

Why shares of mind medicine jumped 13.4% on wednesday

The clinical-stage biopharmaceutical company benefited from an increased interest in companies working ...

February 9, 2022, 5:26 pm

Why shares of mind medicine jumped 13.4% on wednesday

The clinical-stage biopharmaceutical company benefited from an increased interest in companies working ...

February 9, 2022, 5:26 pm

Why shares of mind medicine jumped 13.4% on wednesday

The clinical-stage biopharmaceutical company benefited from an increased interest in companies working ...

February 9, 2022, 5:26 pm

Elite pharmaceuticals, inc. to host conference call to provide corporate update and discuss third quarter 2022 financial results on february 15, 2022

Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022...

February 9, 2022, 5:15 pm

Elite pharmaceuticals, inc. to host conference call to provide corporate update and discuss third quarter 2022 financial results on february 15, 2022

Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022...

February 9, 2022, 5:15 pm

Elite pharmaceuticals, inc. to host conference call to provide corporate update and discuss third quarter 2022 financial results on february 15, 2022

Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022...

February 9, 2022, 5:15 pm

Aurinia pharmaceuticals to release fourth quarter and year end 2021 financial results on february 28, 2021

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...

February 9, 2022, 4:17 pm

Aurinia pharmaceuticals to release fourth quarter and year end 2021 financial results on february 28, 2021

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...

February 9, 2022, 4:17 pm

Aurinia pharmaceuticals to release fourth quarter and year end 2021 financial results on february 28, 2021

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...

February 9, 2022, 4:17 pm

Effector therapeutics to present at 2022 bio ceo & investor conference

SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a bio...

February 9, 2022, 4:00 pm

Effector therapeutics to present at 2022 bio ceo & investor conference

SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a bio...

February 9, 2022, 4:00 pm

Effector therapeutics to present at 2022 bio ceo & investor conference

SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a bio...

February 9, 2022, 4:00 pm

Teva pharmaceutical industries ltd. (teva) ceo kåre schultz on q4 2021 results - earnings call transcript

Teva pharmaceutical Industries Ltd. (TEVA) CEO Kåre Schultz on Q4 2021 Results - Earnings Call Transcr...

February 9, 2022, 12:43 pm

Teva pharmaceutical industries ltd. (teva) ceo kåre schultz on q4 2021 results - earnings call transcript

Teva pharmaceutical Industries Ltd. (TEVA) CEO Kåre Schultz on Q4 2021 Results - Earnings Call Transcr...

February 9, 2022, 12:43 pm

Teva pharmaceutical industries ltd. (teva) ceo kåre schultz on q4 2021 results - earnings call transcript

Teva pharmaceutical Industries Ltd. (TEVA) CEO Kåre Schultz on Q4 2021 Results - Earnings Call Transcr...

February 9, 2022, 12:43 pm

Biomarin sells priority review voucher for $110m

BioMarin pharmaceutical Inc BMRN has agreed to sell the Rare Pediatric Disease Priority Review Voucher...

February 9, 2022, 10:34 am


Search within

Pages Search Results: